2023-03-15
Kristina Torfgård, CEO, participated in Redeye's Alzheimer panel discussion. Read more
2022-12-02
Dr. Anders Sandberg, Chief Scientific Officer, presented data for the Company's preclinical antibody candidate ALZ-201. The poster summarises the… Read more
2021-07-26
Dr. Anders Sandberg, Chief Scientific Officer, presented data on the Company's monoclonal antibody, ALZ-201. The poster features preclinical data… Read more
2022-12-15
Watch our CEO Kristina Torfgård, present Alzinova (in Swedish). Read more
2022-11-16
On November 16, our CEO, Kristina Torfgård, presented at Mangold Insight investor day. Read more
2022-10-24
Watch the new interview (in Swedish). Read more
2022-10-12
Read more
2022-06-08
On June 8, our CEO, Kristina Torfgård, presented at BioStock Life Science Spring Summit. Read more
2022-06-03
Kristina visited Biostock's studio to talk about how Alzinova differs from other companies developing treatments for Alzheimer's disease. She… Read more
2022-05-19
2022-06-02
Alzinova recently participated in the Redeye Growth Day 2 June 2022. Check out the Q&A session with our CEO,… Read more
2022-05-18
2022-05-11
Kristina Torfgård, our CEO, presented Alzinova at Aktieportföljen Live on May 11. Read more
2022-05-03
2022-02-03
Kristina Torfgård, CEO, Anders Sandberg, CSO, and Håkan Skogström, CFO, were interviewed by our Communications Specialist, Jamie Smith, at… Read more
2022-01-26
On January 26, our CEO, Kristina Torfgård, presented Alzinova at Mangold Insight Life Science Investent day. Read more
2022-01-14
Our CEO, Kristina Torfgård presented Alzionva at RedEye Investor Forum Online on January 13. Read more
2022-01-12
Like us, you probably know someone who has, or has had, Alzheimer’s disease. It is a progressively debilitating disease… Read more
2021-12-16
Watch our CEO Krisitna Torfgård present Alzinova at RedEye Investor Forum. Read more
2021-11-24
On November 24 our CEO Kristina Torfgård, presented Alzinova at Aktieportföljen. Read more
2021-11-11
2021-10-20
Alzinova's CEO Kristina Torfgård was interviewed on October 13, 2021 by Redeye’s Life Science analyst Kevin Sule. Read more
2021-10-13
Our CEO, Kristina Torfgård, presented the company at the Redeye Neurology Seminar together with representatives from the other Swedish… Read more
2021-10-11
Kristina Torfgård, CEO presented Alzinova at Aktiespararnas Aktiedag, October 11 2021. Read more
2021-09-24
CEO Kristina Torfgård presented at Redeye Investor Forum, September 23 2021. Read more
2021-06-02
2021-05-17
2021-05-05
2021-04-29
Our CEO, Kristina Torfgård, recently participated in a webcast discussion on Alzheimer's disease together with the CEOs of two… Read more
2021-03-01
Alzinova's CEO Kristina Torfgård was interviewed on February 26, 2021 by Redeye’s Life Science analyst Anders Hedlund. Read more
2020-11-04
Alzinova presented the study design of the upcoming first clinical study with the oligomer-specific therapeutic vaccine ALZ-101 on a… Read more
2020-10-15
Kristina Torfgård, CEO presented Alzinova at Redeye's Neurology Seminar CNS on October 15 - in Swedish… Read more
2020-10-06
Kristina Torfgård, CEO presented Alzinova at Redeye Investor Forum Special - in Swedish… Read more
2020-10-01
Kristina Torfgård, CEO presented Alzinova at Redeye Investor Forum - in Swedish… Read more
2020-09-29
Kristina Torfgård, CEO talks briefly about the Preferential Rights issue in Redeye's "transaction pitch" - in Swedish. Read more
Kristina Torfgård, CEO talks briefly about the company in Redeye's "Company pitch" - in Swedish. Read more
Kristina Torfgård, CEO talks briefly about the company in Redeye's "elevator pitch" - in Swedish. Read more
Kristina Torfgård, CEO presented Alzinova at the Redeye Investor Event - in Swedish… Read more
2020-09-21
Kristina Torfgård, CEO presented Alzinova at Aktiespararnas Aktiedag, September 21 2020 - World Alzheimer's Day… Read more
2020-07-30
Dr. Anders Sandberg, Chief Scientific Officer, presented data on the Company's substances. The poster provides an overview of the… Read more
Alzinova's CEO Kristina Torfgård was interviewed on March 3, 2020 by Redeye’s Life Science analyst Anders Hedlund. Read more
Kristina Torfgård, CEO presented Alzinova at the Redeye Growth Day, Sweden. Read more
